Neuronal acetylcholine receptor alpha9-subunit: a possible central nervous system autoantigen

Area of Science:

• Neuroimmunology
• Molecular Neuroscience
• Autoimmune Disorders

Background:

• Nicotinic acetylcholine receptors (AChRs) are crucial for neuromuscular transmission and neuronal function.
• Myasthenia gravis (MG) is an autoimmune disease primarily targeting muscle AChRs, leading to weakness.
• Rarely, MG patients exhibit central nervous system (CNS) symptoms, suggesting potential involvement beyond the neuromuscular junction.

Purpose of the Study:

• To investigate the potential cross-reactivity of anti-AChR antibodies with CNS AChR subunits in MG.
• To explore the role of neuronal AChR alpha-9 subunit as a potential target antigen in MG-associated CNS symptoms.

Main Methods:

• Analysis of antibody reactivity against CNS antigens in experimental autoimmune myasthenia gravis (EAMG) mouse models.
• Characterization of alpha-9 AChR expression and distribution within the CNS.
• Comparison of antibody binding patterns in EAMG with serum samples from MG patients.

Main Results:

• Preliminary studies detected antibodies reactive with CNS antigens in EAMG mice.
• Neuronal alpha-9 AChR was found to be widely expressed in the CNS.
• Antibody binding patterns in EAMG mice resembled those observed in some MG patient serum samples.

Conclusions:

• Serum anti-AChR antibodies in MG patients may cross-react with CNS AChR subunits, potentially causing CNS symptoms.
• The neuronal alpha-9 AChR subunit is a significant candidate antigen in the autoimmune process underlying rare CNS manifestations of MG.